Harrison Global Holdings Launches ECRUX Investment Platform, Expands into Japan and Taiwan

summarizeSummary

Harrison Global Holdings is launching a new global investment platform, ECRUX, and expanding its venture investment activities into Japan and Taiwan through an acquisition and a joint venture.

check_boxKey Events

• Establishment of ECRUX Investment Platform

  The board approved the creation of a new global investment platform, ECRUX, including forming wholly-owned subsidiaries in the U.S. and Cayman Islands with authorized share capital of up to US$500,000 each. This platform is designed to consolidate and expand the company's venture investment activities.

• Acquisition in Japan

  The company's subsidiary, Bloomz Limited, will acquire 100% equity in CSI Japan Co., Ltd. for approximately JPY 300,000. Following the acquisition, the entity will be renamed ECRUX Venture Partners Japan Inc., marking an expansion into the Japanese market.

• Taiwan Joint Venture Investment

  ECRUX Venture Partners, LLC, a Korean subsidiary, will invest up to JPY 5,000,000 into RIKEN Taiwan Immune Regenerative Medicine Inc., resulting in a 51% ownership stake. This entity will be renamed ECRUX Venture Partners Taiwan Inc., establishing a regional investment platform.

auto_awesomeAnalysis

Harrison Global Holdings Inc. is undertaking a significant strategic restructuring to establish a new global investment platform, ECRUX. This initiative involves forming new subsidiaries in the U.S. and Cayman Islands with substantial authorized capital, alongside an acquisition in Japan and a joint venture investment in Taiwan. While the immediate financial outlays for the acquisition and JV are modest, the overall strategy signals a notable expansion and a shift in the company's investment focus, potentially leading to future capital deployment.